Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
FA complementation group A | 0.505 | 0.731 | 1.6E-68 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1983 | 1983 | ||||||||
|
fumarylacetoacetate hydrolase | 0.612 | 0.538 | 4.0E-17 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1983 | 1983 | ||||||||
|
aconitase 2 | 0.619 | 0.654 | 0.21 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1983 | 1983 | ||||||||
|
CEA cell adhesion molecule 5 | 0.420 | 0.846 | 4.2E-10 |
|
disease | 0.100 | None | 0.990 | 288 | 0 | 1986 | 2020 | ||||||||
|
CEA cell adhesion molecule 3 | 0.494 | 0.731 | 1.1E-09 |
|
disease | 0.100 | None | 0.989 | 90 | 0 | 1986 | 2020 | ||||||||
|
CEA cell adhesion molecule 7 | 0.494 | 0.769 | 1.3E-07 |
|
disease | 0.100 | None | 0.989 | 90 | 0 | 1986 | 2020 | ||||||||
|
pregnancy specific beta-1-glycoprotein 2 | 0.492 | 0.731 | 1.4E-30 |
|
disease | 0.100 | None | 0.988 | 86 | 0 | 1986 | 2020 | ||||||||
|
fibroblast activation protein alpha | 0.496 | 0.808 | 1.9E-28 |
|
disease | 0.100 | None | 1.000 | 16 | 0 | 1987 | 2020 | ||||||||
|
mutS homolog 6 | 0.462 | 0.731 | 3.7E-05 |
|
disease | 0.600 | strong | 0.974 | 107 | 5 | 1988 | 2020 | ||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
disease | 0.100 | None | 0.946 | 37 | 2 | 1988 | 2019 | ||||||||
|
fibroblast growth factor 4 | 0.588 | 0.577 | 0.14 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1988 | 2018 | ||||||||
|
nuclear receptor subfamily 3 group C member 1 | 0.393 | 0.885 | 0.97 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1988 | 2014 | ||||||||
|
histatin 3 | 0.686 | 0.500 | 4.1E-05 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1988 | 1988 | ||||||||
|
sulfotransferase family 2A member 1 | 0.545 | 0.769 | 1.3E-15 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1988 | 1988 | ||||||||
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 0.700 | None | 0.947 | 659 | 14 | 1989 | 2020 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.400 | None | 0.986 | 70 | 2 | 1989 | 2019 | ||||||||
|
major histocompatibility complex, class I, A | 0.370 | 0.846 | 1.3E-03 |
|
disease | 0.100 | None | 1.000 | 14 | 2 | 1989 | 2019 | ||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
disease | 0.140 | None | 1.000 | 4 | 0 | 1989 | 2016 | ||||||||
|
nerve growth factor | 0.391 | 0.885 | 0.82 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1989 | 2011 | ||||||||
|
fibroblast growth factor 3 | 0.505 | 0.808 | 9.3E-05 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1989 | 1989 | ||||||||
|
integrator complex subunit 2 | 0.590 | 0.654 | 1.00 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1989 | 1989 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.600 | None | 0.963 | 1005 | 11 | 1990 | 2020 | ||||||||
|
APC regulator of WNT signaling pathway | 0.373 | 0.962 | 1.00 |
|
disease | 0.800 | strong | 0.972 | 353 | 20 | 1990 | 2020 | ||||||||
|
ATP binding cassette subfamily B member 1 | 0.344 | 0.885 | 1.3E-05 |
|
disease | 0.600 | None | 0.960 | 74 | 7 | 1990 | 2020 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
disease | 0.400 | None | 1.000 | 72 | 0 | 1990 | 2019 |